Drug interaction study aims to improve ovarian cancer treatment

NCT ID NCT07402915

First seen Feb 15, 2026 · Last updated May 16, 2026 · Updated 14 times

Summary

This study looks at how the antifungal drug itraconazole changes the levels of a cancer drug in the blood of people with ovarian, primary peritoneal, or fallopian tube cancer. About 24 participants will take both drugs in a fixed order to measure drug levels over time. The goal is to understand the interaction, not to treat the cancer directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    NOT_YET_RECRUITING

    Batumi, 6010, Georgia

  • Research Site

    NOT_YET_RECRUITING

    Tbilisi, 0114, Georgia

  • Research Site

    NOT_YET_RECRUITING

    Tbilisi, 112, Georgia

  • Research Site

    RECRUITING

    Dublin, D07 R2WY, Ireland

  • Research Site

    RECRUITING

    Lisbon, 1250-068, Portugal

  • Research Site

    RECRUITING

    Barcelona, 08023, Spain

  • Research Site

    RECRUITING

    Logroño, 26006, Spain

  • Research Site

    RECRUITING

    Madrid, 28040, Spain

  • Research Site

    RECRUITING

    Madrid, 28050, Spain

Conditions

Explore the condition pages connected to this study.